Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENDER trial of genotype-guided nortriptyline for functional dyspepsia
NL-OMON52924Phase 3Completed
- Sponsor
- Maastricht University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nortriptyline in functional dyspepsia (FD) (3 arms), sponsored by Maastricht University. Primary endpoints: Symptom response to therapy, Weekly global adequate relief and 1 more. Started Oct 2018; status: completed.
02
Drugs
nortriptyline
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NL-OMON52924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52924.